Markov, A.V.; Ilyina, A.A.; Salomatina, O.V.; Sen’kova, A.V.; Okhina, A.A.; Rogachev, A.D.; Salakhutdinov, N.F.; Zenkova, M.A.
Novel Soloxolone Amides as Potent Anti-Glioblastoma Candidates: Design, Synthesis, In Silico Analysis and Biological Activities In Vitro and In Vivo. Pharmaceuticals 2022, 15, 603.
https://doi.org/10.3390/ph15050603
AMA Style
Markov AV, Ilyina AA, Salomatina OV, Sen’kova AV, Okhina AA, Rogachev AD, Salakhutdinov NF, Zenkova MA.
Novel Soloxolone Amides as Potent Anti-Glioblastoma Candidates: Design, Synthesis, In Silico Analysis and Biological Activities In Vitro and In Vivo. Pharmaceuticals. 2022; 15(5):603.
https://doi.org/10.3390/ph15050603
Chicago/Turabian Style
Markov, Andrey V., Anna A. Ilyina, Oksana V. Salomatina, Aleksandra V. Sen’kova, Alina A. Okhina, Artem D. Rogachev, Nariman F. Salakhutdinov, and Marina A. Zenkova.
2022. "Novel Soloxolone Amides as Potent Anti-Glioblastoma Candidates: Design, Synthesis, In Silico Analysis and Biological Activities In Vitro and In Vivo" Pharmaceuticals 15, no. 5: 603.
https://doi.org/10.3390/ph15050603
APA Style
Markov, A. V., Ilyina, A. A., Salomatina, O. V., Sen’kova, A. V., Okhina, A. A., Rogachev, A. D., Salakhutdinov, N. F., & Zenkova, M. A.
(2022). Novel Soloxolone Amides as Potent Anti-Glioblastoma Candidates: Design, Synthesis, In Silico Analysis and Biological Activities In Vitro and In Vivo. Pharmaceuticals, 15(5), 603.
https://doi.org/10.3390/ph15050603